219 related articles for article (PubMed ID: 29455115)
21. Mometasone furoate/formoterol in the treatment of persistent asthma.
Berger WE
Expert Rev Respir Med; 2011 Dec; 5(6):739-46. PubMed ID: 22082160
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication?
Sadowska AM; Klebe B; Germonpré P; De Backer WA
Steroids; 2007 Jan; 72(1):1-6. PubMed ID: 17145070
[TBL] [Abstract][Full Text] [Related]
23. Steroid response in refractory asthmatics.
Jang AS
Korean J Intern Med; 2012 Jun; 27(2):143-8. PubMed ID: 22707883
[TBL] [Abstract][Full Text] [Related]
24. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
[TBL] [Abstract][Full Text] [Related]
25. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
Brassington K; Selemidis S; Bozinovski S; Vlahos R
Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
[TBL] [Abstract][Full Text] [Related]
27. Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome.
Rhee CK
Korean J Intern Med; 2015 Jul; 30(4):443-9. PubMed ID: 26161009
[TBL] [Abstract][Full Text] [Related]
28. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
[TBL] [Abstract][Full Text] [Related]
29. World Asthma and COPD Forum. Tackling asthma, COPD and allergic diseases.
D'Amato G
IDrugs; 2008 Jul; 11(7):486-8. PubMed ID: 18600593
[No Abstract] [Full Text] [Related]
30. Treatment of overlapping asthma-chronic obstructive pulmonary disease: Can guidelines contribute in an evidence-free zone?
Reddel HK
J Allergy Clin Immunol; 2015 Sep; 136(3):546-52. PubMed ID: 26343938
[TBL] [Abstract][Full Text] [Related]
31. Understanding the pathophysiology of the asthma-chronic obstructive pulmonary disease overlap syndrome.
Gelb AF; Nadel JA
J Allergy Clin Immunol; 2015 Sep; 136(3):553-5. PubMed ID: 26343939
[No Abstract] [Full Text] [Related]
32. Pharmacological effects of lysozyme on COPD and bronchial asthma with sputum: A randomized, placebo-controlled, small cohort, cross-over study.
Ohbayashi H; Setoguchi Y; Fukuchi Y; Shibata K; Sakata Y; Arai T
Pulm Pharmacol Ther; 2016 Apr; 37():73-80. PubMed ID: 26952317
[TBL] [Abstract][Full Text] [Related]
33. Recent Patents for the Treatment of Asthma.
El-Qutob D; Raducan I
Recent Pat Inflamm Allergy Drug Discov; 2016; 10(1):13-20. PubMed ID: 27262358
[TBL] [Abstract][Full Text] [Related]
34. Btk Inhibitor RN983 Delivered by Dry Powder Nose-only Aerosol Inhalation Inhibits Bronchoconstriction and Pulmonary Inflammation in the Ovalbumin Allergic Mouse Model of Asthma.
Phillips JE; Renteria L; Burns L; Harris P; Peng R; Bauer CM; Laine D; Stevenson CS
J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):233-41. PubMed ID: 27111445
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease.
Spears M; McSharry C; Thomson NC
Clin Exp Allergy; 2006 Dec; 36(12):1494-504. PubMed ID: 17177672
[TBL] [Abstract][Full Text] [Related]
36. Hydrogen coadministration slows the development of COPD-like lung disease in a cigarette smoke-induced rat model.
Liu X; Ma C; Wang X; Wang W; Li Z; Wang X; Wang P; Sun W; Xue B
Int J Chron Obstruct Pulmon Dis; 2017; 12():1309-1324. PubMed ID: 28496315
[TBL] [Abstract][Full Text] [Related]
37. Comparison table: some inhaled drugs for treatment of asthma.
Med Lett Drugs Ther; 2017 Aug; 59(1528):e146-e149. PubMed ID: 28880850
[No Abstract] [Full Text] [Related]
38. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
[TBL] [Abstract][Full Text] [Related]
39. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
Moretti M; Fagnani S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
[TBL] [Abstract][Full Text] [Related]
40. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
